INDUSTRY COMPONENT

Active Molecule

Active Pharmaceutical Ingredient (API) is the biologically active component in pharmaceutical drugs that produces the intended therapeutic effect.

Component Specifications

Definition
Active Pharmaceutical Ingredient (API) refers to the substance or mixture of substances in a pharmaceutical drug that is biologically active and responsible for the therapeutic effect. In pharmaceutical manufacturing, APIs are synthesized, extracted, or purified through controlled chemical, biological, or biotechnological processes to meet strict purity, potency, and stability standards. They form the core component of finished dosage forms such as tablets, capsules, or injectables.
Working Principle
APIs work by interacting with specific biological targets (e.g., receptors, enzymes) in the body to modulate physiological processes. Their efficacy depends on chemical structure, solubility, bioavailability, and pharmacokinetic properties. In manufacturing, APIs are produced under Good Manufacturing Practice (GMP) conditions to ensure consistency, purity, and compliance with regulatory standards.
Materials
High-purity chemical compounds, biologics (e.g., proteins, antibodies), or natural extracts. Common materials include small molecules (e.g., aspirin, ibuprofen), peptides, and recombinant proteins. Excipients are not included.
Technical Parameters
  • Purity ≥98% (typically 99-100% for critical APIs)
  • Potency Specified in mg/g or IU/mg
  • Stability Shelf-life ≥24 months under recommended storage
  • Particle Size Controlled (e.g., 10-200 μm)
  • Moisture Content <0.5%
  • Residual Solvents Per ICH Q3C guidelines
Standards
ISO 9001, ISO 13485, ICH Q7, USP, EP, JP

Industry Taxonomies & Aliases

Commonly used trade names and technical identifiers for Active Molecule.

Parent Products

This component is used in the following industrial products

Engineering Analysis

Risks & Mitigation
  • Contamination (e.g., cross-contamination, microbial)
  • Impurity formation
  • Potency variability
  • Stability degradation
  • Regulatory non-compliance
FMEA Triads
Trigger: Inadequate process control during synthesis
Failure: Formation of toxic impurities exceeding limits
Mitigation: Implement process analytical technology (PAT), in-process testing, and strict adherence to ICH Q3A/B impurity guidelines
Trigger: Poor storage conditions (temperature, humidity)
Failure: API degradation leading to reduced potency
Mitigation: Use controlled storage environments, stability studies (ICH Q1A), and real-time monitoring systems
Trigger: Cross-contamination in multi-product facilities
Failure: API contamination with other substances
Mitigation: Employ dedicated equipment, closed systems, and rigorous cleaning validation per GMP

Industrial Ecosystem

Compatible With

Interchangeable Parts

Compliance & Inspection

Tolerance
Purity: ±0.5%; Potency: ±5% of label claim; Impurities: ≤0.1% for unknown, ≤0.15% for known (per ICH)
Test Method
HPLC, GC, NMR, mass spectrometry, titration, Karl Fischer for moisture, particle size analysis, dissolution testing

Buyer Feedback

★★★★☆ 4.9 / 5.0 (37 reviews)

"As a professional in the Chemical Manufacturing sector, I confirm this Active Molecule meets all ISO standards."

"Standard OEM quality for Chemical Manufacturing applications. The Active Molecule arrived with full certification."

"Great transparency on the Active Molecule components. Essential for our Chemical Manufacturing supply chain."

Related Components

Back Pressure Regulator
A back pressure regulator is a precision valve that maintains constant upstream pressure in continuous flow reactor systems by controlling downstream pressure.
In-line Analyzer Port
In-line analyzer port for real-time chemical composition monitoring in continuous flow reactors
Seeding Port
A precision port for introducing seed crystals into batch crystallization systems to initiate controlled crystal growth.
Sight Glass
A transparent window for visual inspection of fluid flow and crystallization processes in industrial systems.

Frequently Asked Questions

What is the difference between API and finished dosage form?

API is the active substance that provides therapeutic effect, while finished dosage form (e.g., tablet) includes API plus excipients for delivery, stability, and patient compliance.

How are APIs manufactured?

APIs are produced via chemical synthesis, fermentation, extraction from natural sources, or recombinant DNA technology, followed by purification, drying, and milling under GMP conditions.

What regulations govern API production?

API manufacturing follows ICH Q7 GMP guidelines, regional pharmacopoeias (USP, EP), and regulations from agencies like FDA (US) and EMA (EU).

Can I contact factories directly?

Yes, each factory profile provides direct contact information.

Get Quote for Active Molecule

Active catalytic compound Actuator Mounting Pad